Person:
TORUN, EMEL

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır.
Organizational Units
Organizational Unit
Job Title
First Name
EMEL
Last Name
TORUN
Name
Email Address
Birth Date

Search Results

Now showing 1 - 2 of 2
  • PublicationOpen Access
    Assessment of motor development using the Alberta Infant Motor Scale in full-term infants.
    (2020-01-01T00:00:00Z) Kepenek-Varol, B; Hoşbay, Z; Varol, S; Torun, EMEL; TORUN, EMEL
    The Alberta Infant Motor Scale (AIMS) is a well-known, norm-referenced scale that evaluates the gross motor development of children from birth to 18 months. The aim of the study was to compare the Canadian norms with the AIMS scores of a Turkish sample of infants, and to investigate whether the current reference values of the AIMS are representative for Turkish full-term infants. The study was conducted with 411 Turkish infants of both sexes (195 girls and 216 boys), born with gestational age 38 weeks and older, weighing ≥2500 g at birth. Motor performance of all the cases at different ages were assessed with the AIMS which was used by a physiotherapist. The mean AIMS scores of Turkish infants were compared with the norm values of the original AIMS established in a Canadian sample of infants. The results showed no statistically significant differences between the AIMS scores of Turkish and Canadian infants during the first 18 months of life except at 0-<1 and 2-<3 months of age. The AIMS scores were significantly lower in Turkish infants than in Canadian infants at 0-<1 (p=0.025) and 2-<3 (p=0.042) months of age. In conclusion, the AIMS can be used in Turkish children to assess gross motor development, especially after 4 months of age. However, this paper was presented as a preliminary study to compare AIMS results between Turkish and Canadian infants, and further studies are needed to realize the Turkish validation of AIMS.
  • PublicationMetadata only
    Association of Myeloperoxidase Gene Polymorphism With Iron Deficiency Anemia in Turkish Children
    (2021-10-01T00:00:00Z) USTABAŞ KAHRAMAN, Feyza; ÇAKIR, FATMA BETÜL; BUHUR PİRİMOĞLU, MELTEM; TORUN, EMEL; Ergen, Hayriye Arzu; DOĞAN DEMİR, AYŞEGÜL; USTABAŞ KAHRAMAN, FEYZA; ÇAKIR, FATMA BETÜL; TORUN, EMEL; DOĞAN DEMİR, AYŞEGÜL
    This study was performed to investigate the gene polymorphisms of the myeloperoxidase (MPO) enzyme and to determine whether MPO gene polymorphisms influence the response to iron therapy in pediatric patients with iron deficiency anemia (IDA). In this case-control study, 50 Turkish children with IDA and 50 healthy controls were enrolled. Three MPO gene alleles were selected for genotyping in the study: GG, AG, and AA. The relationships of alleles with IDA were analyzed and compared in patients and controls. Pretreatment and posttreatment laboratory parameters and gene polymorphisms were compared in the patient group. There was a significant difference between patients with IDA and controls regarding genotype frequencies of the AA, GG, and AG alleles (P=0.005). However, the AG allele was found to be associated with variations in hemoglobin, red blood cell, hematocrit, mean corpuscular volumes, and mean corpuscular Hb concentrations levels. The frequency of AA, GG, and AG alleles of the MPO gene was potentially associated with changes in iron metabolism and the AG allele led to variations in various hemogram parameters.